| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4241346 | Journal of Vascular and Interventional Radiology | 2008 | 7 Pages |
Abstract
In a prospective patient cohort with a projected 3-month mortality rate of nearly 21.0% as a result of severe prognoses, the success of insertion via various venous access routes and the appropriateness and safety of the VenaTech LP caval filter were assessed. Findings at 90-day follow-up were free of symptomatic PE and device-related adverse effects.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Alain F. MD, PhD, Abla MD, Philippe MD, Rafael Oteros MD, Guglielmo MD, Jean-Baptiste MD, PhD, Christian MD, European VenaTech LP Vena Cava Filter Study Group European VenaTech LP Vena Cava Filter Study Group,